Search
Search Results
##search.searchResults.foundPlural##
-
TREATMENT OF ADVANCED SYSTEMIC MASTOCYTOSIS WITH MIDOSTAURIN: PRACTICAL GUIDANCE FOR OPTIMAL THERAPY AND MANAGEMENT Advanced systemic mastocytosis and midostaurin
1435PDF: 1124HTML: 457 -
Interstitial pneumonia triggered by H1N1 influenza A virus as the initial presentation of chronic myeloid leukemia
948PDF: 564HTML: 255Suppl. Files: 357 -
Idiopathic pulmonary embolism in a case of severe family ANKRD26 thrombocytopenia
2382PDF: 906HTML: 979Patient’s family tree: 236 -
Brief tale of a bacteraemia by Rhodococcus equi with concomitant lung mass: what came first, the chicken or the egg?
1505PDF: 887HTML: 8683Fig 3 Savini: 234Fig 2 Savini: 238Fig 1 Savini Chest TC: 234Author letter to referees: 238 -
CMV IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
5001PDF: 1896HTML: 2886Untitled: 315 -
Allogeneic transplantation in patients with advanced systemic mastocytosis: case report of a single center experience Allogeneic Transplantation in Systemic Mastocytosis
2154PDF: 171HTML: 47 -
ATRA induced Reactive Hemophagocytosis: A Case Report
1310PDF: 658HTML: 2921ATRA induced Reactive Hemophagocytosis: A Case Report: 244 -
THE ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION IN FOLLICULAR LYMPHOMA IN THE NEW DRUGS ERA.
4221PDF: 1237HTML: 2121Fig.1: 248Fig. 2: 142Table 1: 254Table2: 275Table 3: 259 -
OPTIMIZING TREATMENT, MINIMIZING RISK: THERAPEUTIC DRUG MONITORING IN HEMATOLOGICAL MALIGNANCIES
1806PDF: 2042Suppl. Files: 289HTML: 123 -
ANTIBACTERIAL RESISTANCE IN PATIENTS WITH HEMATOPOIETIC STEM CELL TRANSPLANTATION
4221PDF: 1329HTML: 2128Table 1: 238 -
SOCIOECONOMIC STATUS IS GLOBALLY A PROGNOSTIC FACTOR FOR OVERALL SURVIVAL OF MULTIPLE MYELOMA PATIENTS; SYNTHESIS OF STUDIES AND REVIEW OF THE LITERATURE SES as prognostic factor for myeloma survival
2292PDF: 922HTML: 380 -
EPIDEMIOLOGY OF INVASIVE FUNGAL INFECTIONS IN THE MEDITERRANEAN AREA
2363PDF: 1069HTML: 4993 -
Anemia in the elderly: not always what it seems.
3433PDF: 1154HTML: 1814Figure 1: 246Figure 1 revised: 267 -
SARS-CoV-2 (COVID-19) and Chronic Myeloid Leukemia (CML): a case report and review of ABL kinase involvement in viral infection CML and COVID-19
3445PDF: 1627HTML: 562 -
TUBERCULOSIS IN PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES
3571PDF: 1340HTML: 8424 -
OUTBREAK OF BURKHOLDERIA CEPACIA INFECTION: A SYSTEMATIC STUDY IN A HEMATOLOGY-ONCOLOGY UNIT OF A TERTIARY CARE HOSPITAL FROM EASTERN INDIA.
2430PDF: 1026HTML: 528Outbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern India: 269UntitOutbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern Indialed: 411Outbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern India: 309Outbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern India: 225Outbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern India: 240Outbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern India: 321 -
ANTIFUNGAL THERAPY IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
4958PDF: 1634HTML: 2278Untitled: 278Untitled: 298Untitled: 315Untitled: 268Untitled: 279 -
OUTCOME OF ANTIFUNGAL COMBINATION THERAPY FOR INVASIVE MOLD INFECTIONS IN HEMATOLOGICAL PATIENTS IS INDEPENDENT OF THE CHOSEN COMBINATION
1307PDF: 587HTML: 1719Figures: 213Fifures Sanz: 224tables Sanz: 227Untitled: 224 -
TREATMENT OF CANCER IN THE OLDER AGED PERSON
1281PDF: 884HTML: 3421 -
ESCHERICHIA COLI: AN IMPORTANT PATHOGEN IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES
2474PDF: 800HTML: 2157Untitled: 283Untitled: 200Untitled: 233Untitled: 212Untitled: 227Untitled: 248Untitled: 235 -
The diagnostic sensitivity of beta-D-glucan assay in patients with chronic disseminated candidiasis
1398PDF: 1183PDF: 955HTML: 267







